| MAP3K7IP1 antibodies | |
| This is a review about TAB1 antibodies, based on 3 published articles using TAB1 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited TAB1 antibody. Information in this review (with links to publications) can be searched freely. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology MAP3K7IP1 products
includes other brands or spellings
|
| wb | | Santa Cruz Biotechnology anti-TAB1 antibody N-19 was used in western blot to study the combination of TAK1 with the tumor necrosis factor-α (TNF-α) receptor 1 complex which leading to NF-κB activation with MEKK3. |
| wb | | Santa Cruz Biotechnologies anti-TAB1 antibody (C-20) was used in HeLa (A) and HEK293 cells and in western blot to study the regulatory mechanisms for the phosphorylation of p65 on Ser-536 under physiological conditions. |
| wb | | Santa Cruz Biotechnology polyclonal goat anti-TAB1 (N-19) antibody was used in western blot to study the interaction between TAB1 isoform and p38alpha. |
Articles Reviewed |
| 1. Baoxue Ge et al. TAB1beta (transforming growth factor-beta-activated protein kinase 1-binding protein 1beta ), a novel splicing variant of TAB1 that interacts with p38alpha but not TAK1. 2003 |
| 2. Hiroaki Sakurai et al. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. 2003 |
| 3. Marzenna Blonska et al. TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation. 2005 |
|